Advertisement
News
Subscribe to MDT Magazine News

AIKO Biotechnology steps back to reformulate, seek financing

February 15, 2011 9:37 am | by Mass High Tech: The Journal of New England Technology | Comments

AIKO Biotechnology Inc., a Portland, Maine, company focused on drug candidates to relieve the side effects from long-term prescription opioid pain reliever use, is taking a step back to reformulate its lead compound from an injectable into a pill.

Boston Scientific endowment recognizes Baim

February 15, 2011 7:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Boston Scientific Corp. said today that it has established a $1.7 million endowment for a scholarship fund at the Yale University School of Medicine in honor of the Boston Scientific chief medical and science officer Donald S. Baim, who died unexpectedly in 2009.

BIO study shows drug approval success rate slips

February 15, 2011 7:32 am | by Mass High Tech: The Journal of New England Technology | Comments

The Biotechnology Industry Organization (BIO) released a study Monday that shows a significant drop in the ratio of drugs moving through clinical studies and gaining U.S. Food and Drug Administration approval.

Advertisement

Endologix Announces Presentation of Favorable Initial PEVAR Trial Results

February 15, 2011 7:32 am | by Bio-Medicine.Org | Comments

IRVINE, Calif., Feb. 15, 2011 /- Endologix, Inc. (Nasdaq: ELGX ), developer of minimally invasive treatments for aortic disorders, announced today the presentation of the initial clinical results from the PEVAR Trial at the 2011 iCON (International Congress of Endovascular Specialists)...

TOPICS:

Baxter Intl declares dividend, names officers

February 15, 2011 6:45 am | by The Associated Press | Comments

Drug and medical device maker Baxter International Inc. said Tuesday its board declared a quarterly dividend of 31 cents per share.The Deerfield, Ill., company said the dividend is payable April 1 to shareholders of record as of the close of business March 10.Baxter also said it named Chief...

United Therapeutics turns 4Q profit as sales grow

February 15, 2011 6:45 am | by The Associated Press | Comments

United Therapeutics Corp. said Tuesday it turned a fourth-quarter profit as revenue jumped 53 percent, led by growth from the biotechnology company's blood pressure treatments Remodulin and Tyvaso.The Silver Spring, Md., company earned $9.5 million, or 15 cents per share, in the three months...

First Medical-Grade Consumer Sleep Assessment Monitor Has Wristwatch Form-Factor And Uses Nordic 2.4ghz ANT Transceivers

February 15, 2011 6:42 am | Comments

The ReadiBandâ„¢ from Fatigue Science is the only consumer friendly, scientifically validated sleep assessment product to provide medical grade results without requiring users to stay overnight in a specialist sleep clinic.

TOPICS:

New Faces of Engineering 2011 Honors Brianne Maier

February 15, 2011 6:37 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., WASHINGTON, D.C., February 14, 2011 — They are the best of the best — the next generation of engineers whose innovation, leadership skills and commitment to excellence are helping to better our world and inspire young people to consider a career in...

Advertisement

DJO Incorporated Completes Business Integration and Changes Name to DJO Global, Inc.

February 15, 2011 6:36 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Feb. 15, 2011 /PRNewswire/ -- DJO Global, Inc., previously DJO Incorporated, a global provider of medical device solutions for musculoskeletal health, vascular health, and pain management, today announced that it has changed its name in recognition of the successful completion...

TOPICS:

Dynatronics Announces $1 Million Stock Buyback Program

February 15, 2011 6:36 am | by Bio-Medicine.Org | Comments

SALT LAKE CITY, Feb. 15, 2011 /- Dynatronics Corporation (Nasdaq: DYNT ) today announced that its board of directors has approved a $1 million open market share repurchase program of the company's common stock.   "This decision reflects the confidence of management and our board of...

TOPICS:

HealthWarehouse.com Acquires Online Division of Hocks Pharmacy

February 15, 2011 6:36 am | by Bio-Medicine.Org | Comments

CINCINNATI, Feb. 15, 2011 /- HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA), a leading retail mail-order pharmacy, today announced that it has consummated two separate transactions to acquire all the online assets of Hock Pharmacy, an online reseller of over-the-counter medications,...

TOPICS:

Fred Funk Becomes Spokesperson for Stryker Orthopaedics

February 15, 2011 6:36 am | by Bio-Medicine.Org | Comments

MAHWAH, N.J., Feb. 15, 2011 /- Stryker Corporation's Orthopaedics Division today announced that Fred Funk, one of the most recognizable names and personalities in professional golf, has become a spokesperson for the company. A 20-year veteran of the sport and current member of the PGA...

TOPICS:

New Study Finds Temporal Artery Thermometry Equivalent to Rectal Thermometry

February 15, 2011 6:36 am | by Bio-Medicine.Org | Comments

WATERTOWN, Mass., Feb. 15, 2011 /- Measuring the body temperatures of newborns with temporal artery thermometry is as accurate as using rectal thermometers, according to a cross-sectional study recently published in Paediatrica Indonesiana.  Quick, safe and accurate thermometry...

TOPICS:

NASDAQ Removes TLCR From Biotechnology Index Pending FTC Decision on Grifols Acquisition

February 15, 2011 6:35 am | by Bio-Medicine.Org | Comments

RESEARCH TRIANGLE PARK, N.C., Feb. 15, 2011 /- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR ) announced today that NASDAQ has removed TLCR from the NASDAQ Biotechnology Index(R) (Nasdaq: NBI) in anticipation of the company's pending acquisition by Grifols S.A. The change takes...

TOPICS:

Jefferson researchers provide genetic evidence that antioxidants can help treat cancer

February 15, 2011 6:34 am | by EurekAlert | Comments

(Thomas Jefferson University) Researchers from Jefferson's Kimmel Cancer Center have genetic evidence suggesting the antioxidant drugs currently used to treat lung disease, malaria and even the common cold can also help prevent and treat cancers because they fight against mitochondrial...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading